Cubicin (daptomycin) / Merck (MSD)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cubicin (daptomycin) / Merck (MSD)
2017-002888-18: Traitement des méningites à pneumocoque

Not yet recruiting
2
128
Europe
Daptomycine, Powder for solution for injection/infusion, CUBICIN
CHU Dijon Bourgogne
méningite à pneumocoque, méningite bactérienne, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
NCT04775953: DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia

Completed
2
200
Canada, US
Cefazolin, Dalbavancin, Daptomycin, Nafcillin, Oxacillin, Vancomycin
National Institute of Allergy and Infectious Diseases (NIAID)
Staphylococcal Bacteraemia
10/23
12/23
NCT04983901: PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN

Completed
2
100
US
Imipenem/Cilastatin/Relebactam, RECARBRIO™, Cefepime, Meropenem, Meropenem Trihydrate, Merrem I.V., SM-7338, Piperacillin-Tazobactam, PIPER/TAZO, Piperacillin/Tazobactam, Zosyn, Vancomycin, Daptomycin, Cubicin, LY146032, Linezolid, Zyvox
M.D. Anderson Cancer Center, Merck Sharp & Dohme LLC
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
10/23
10/23
AddaMAP, NCT03480191: Adjunction of Daptomycin for the Treatment of Pneumococcal Meningitis

Recruiting
2
128
Europe
Daptomycin
Centre Hospitalier Universitaire Dijon
Pneumococcal Meningitis
06/24
09/24
2009-018212-26: Etude de la diffusion de la daptomycinedans le tissu osseux et le liquide synovialchez le volontaire sain après injection unique

Ongoing
1/2
21
Europe
CUBICIN, CUBICIN
Centre Hospitalier Universitaire de Besançon
La condition mpédicale étudiée est la diffusion osseuse de la daptomycine. Pour l\'étudier, nous avons choisi de faire une étude interventionnelle prospective monocentrique de phase 1 chez le volontaire sain.
 
 

Download Options